Wayne Paterson - Anteris Technologies Non-Executive Independent Director
Director
Mr. Wayne G. Paterson is the Chief Executive Officer, Director of the Company. Mr Paterson joined the Admedus board in 2015 having spent 25 years in the Global Pharmaceutical industry managing diverse and complex global operations at Roche and Merck. Over his career he was responsible for substantial revenues and operations and held the positions of President Europe, Canada and Australia, President of Emerging markets, President of Japan, Global head of Cardiovascular and general medicine amongst others. Mr Paterson is also a NonExecutive Director of a NASDAQ listed molecular diagnostics company since 2017.
| Age | 56 |
| Tenure | 8 years |
| Phone | 61 13 0055 0310 |
| Web | https://www.anteristech.com |
Anteris Technologies Management Efficiency
The company has return on total asset (ROA) of (0.8433) % which means that it has lost $0.8433 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.5517) %, meaning that it generated substantial loss on money invested by shareholders. Anteris Technologies' management efficiency ratios could be used to measure how well Anteris Technologies manages its routine affairs as well as how well it operates its assets and liabilities.Anteris Technologies has accumulated 4.07 M in total debt with debt to equity ratio (D/E) of 0.13, which may suggest the company is not taking enough advantage from borrowing. Anteris Technologies has a current ratio of 4.22, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Anteris Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Anteris Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Anteris Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Anteris to invest in growth at high rates of return. When we think about Anteris Technologies' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 1 records | DIRECTOR Age | ||
| ChihHeng Lu | Ainos Inc | 44 | |
Management Performance
| Return On Equity | -2.55 | |||
| Return On Asset | -0.84 |
Anteris Technologies Leadership Team
Elected by the shareholders, the Anteris Technologies' board of directors comprises two types of representatives: Anteris Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Anteris. The board's role is to monitor Anteris Technologies' management team and ensure that shareholders' interests are well served. Anteris Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Anteris Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| AC FAA, Exec | ||
| Wayne Paterson, Non-Executive Independent Director | ||
| Matthew McDonnell, Chief Officer | ||
| David Denis, Chief Officer | ||
| Stephen Denaro, Independent Sec | ||
| Chris Olig, Bus Director | ||
| Danny Zanardo, Commercial International | ||
| MPH MD, Chief Board |
Anteris Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Anteris Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.55 | |||
| Return On Asset | -0.84 | |||
| Operating Margin | (5.05) % | |||
| Current Valuation | 196.49 M | |||
| Shares Outstanding | 13.9 M | |||
| Shares Owned By Insiders | 13.27 % | |||
| Shares Owned By Institutions | 28.34 % | |||
| Price To Earning | (3.20) X | |||
| Price To Book | 10.09 X | |||
| Price To Sales | 30.51 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Anteris Pink Sheet
If you are still planning to invest in Anteris Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anteris Technologies' history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |